Valerie Barton, PhD candidate in the lab of CU Cancer Center researcher, Jennifer Richer, PhD, shows that even triple negative breast cancers with few androgen receptors respond to anti-androgen therapy.
Like a car's bumper, telomeres protect chromosomes. CU Cancer Center study in SCIENCE shows that improper repair can cause cancer.
Study Pinpoints How RhoGDI2 Suppresses Bladder Cancer Metastasis
February 12, 2015 · No comments
Discovery that RhoGDI2 blocks action of RhoC to suppress tumors may finally provide a druggable target allowing researchers to manipulate this signaling in a way that reduces tumor metastasis.
"Now that patients are living longer with cancer and after cancer, it is becoming more and more important to look at how survivors are living. What is their quality of life and how can we help make it better?" says Whitney Jones, PhD.
A University of Colorado Cancer Center study published in the journal PLoS One finds alterations in expression of genes PIK3R3 and PTEN, more commonly observed in adult tumors, in the rare, young-adult bone cancer Ewing Sarcoma, potentially offering ways to improve therapy.
"If we don’t address the feasibility of actually delivering these breakthroughs to patients in the real world they will not be breakthroughs at all," write Camidge and Atherly.
Phase 1 Clinical Trial of CUDC-101 “Throws Kitchen Sink” at Head and Neck Cancer
January 26, 2015 · Comments Off
Clinical Trial of CUCD-101 shows activity against drivers of head and neck cancer, EGFR, Her2 and HDAC
Study: Campus Debit Cards Let Students Buy Cigarettes With Parents’ Money
January 7, 2015 · Comments Off
A University of Colorado Cancer Center study published in the British Medical Journal: Tobacco Control shows that of the top 100 universities as ranked by U.S. News and World Report, 11 allow tobacco sales and 13 allow e-cigarette sales on "campus cash" debit cards that are commonly pre-paid by parents.
Cancer-Causing Mutation Discovered in 1982 Finally Target of Clinical Trials
December 30, 2014 · Comments Off
A recent article in the journal Cancer Discovery describes clinical trials at the University of Colorado Cancer Center and elsewhere that match drugs to long-overlooked oncogene, TRK, offering targeted treatment options for cancers that harbor these gene abnormalities.
Bitter melon juice prevents pancreatic cancer in mouse models
December 30, 2014
Promising Breast and Ovarian Cancer Treatment Vaccine Comes to UCH
December 30, 2014
7th Annual Learn About Cancer Day Returns to CU Cancer Center
February 25, 2015 · No comments
amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno ASCO biomarkers bladder cancer breast cancer cancer cancer grants cancer research colorado Cancer Survivorship clinical trial colon cancer colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu enzalutamide fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma ovarian cancer Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
Not related to cancer-but interesting. We know you've seen the dress. Here is the explanation behind it...ow.ly/JJSOK